Objective: Type 2 diabetes mellitus (DM) accelerates brain aging and cognitive decline. Complex interactions between hyperglycemia, glycemic variability and brain aging remain unresolved. This study investigated the relationship between glycemic variability at multiple time scales, brain volumes and cognition in type 2 DM. Research Design and Methods: Forty-three older adults with and 26 without type 2 DM completed 72-hour continuous glucose monitoring, cognitive tests and anatomical MRI. We described a new analysis of continuous glucose monitoring, termed Multi-Scale glycemic variability (Multi-Scale GV), to examine glycemic variability at multiple time scales. Specifically, Ensemble Empirical Mode Decomposition was used to identify five u...
ObjectivesAbnormally high glucose levels (dysglycemia) increase with age. Epidemiological studies su...
Type 2 diabetes predicts accelerated cognitive decline and brain atrophy. We hypothesized that impai...
<p>At night, glycemic variability declined in type 2 DM in GVC<sub>2–4</sub> and in controls in GVC<...
Type 2 diabetes mellitus (DM) accelerates brain aging and cognitive decline. Complex interactions be...
<div><p>Objective</p><p>Type 2 diabetes mellitus (DM) accelerates brain aging and cognitive decline....
Diabetes is associated with cognitive decline as well as the development of dementia. Although mean ...
Diabetes is associated with cognitive decline as well as the development of dementia. Although mean ...
The mean amplitude of glycemic excursions (MAGE) is a significant deter-minant of overall metabolic ...
Background and Purpose Diabetes is associated with cognitive decline as well as the development of d...
Type 2 diabetes is associated with cognitive dysfunction and structural brain changes. Abnormalities...
ObjectiveTo evaluate the possible early consequences of impaired glucose metabolism on the brain by ...
Objective: We investigated type 2 diabetes mellitus (T2DM) as a risk factor for brain atrophy and gl...
Abstract—Background: Postprandial plasma glucose (PPG) excursion is a significant determinant of ove...
International audienceBackground: Glucometabolic changes, such as high glycemic load (GL) diet and i...
Type 2 diabetes mellitus (T2DM) is becoming increasingly prevalent in the US, especially in older ad...
ObjectivesAbnormally high glucose levels (dysglycemia) increase with age. Epidemiological studies su...
Type 2 diabetes predicts accelerated cognitive decline and brain atrophy. We hypothesized that impai...
<p>At night, glycemic variability declined in type 2 DM in GVC<sub>2–4</sub> and in controls in GVC<...
Type 2 diabetes mellitus (DM) accelerates brain aging and cognitive decline. Complex interactions be...
<div><p>Objective</p><p>Type 2 diabetes mellitus (DM) accelerates brain aging and cognitive decline....
Diabetes is associated with cognitive decline as well as the development of dementia. Although mean ...
Diabetes is associated with cognitive decline as well as the development of dementia. Although mean ...
The mean amplitude of glycemic excursions (MAGE) is a significant deter-minant of overall metabolic ...
Background and Purpose Diabetes is associated with cognitive decline as well as the development of d...
Type 2 diabetes is associated with cognitive dysfunction and structural brain changes. Abnormalities...
ObjectiveTo evaluate the possible early consequences of impaired glucose metabolism on the brain by ...
Objective: We investigated type 2 diabetes mellitus (T2DM) as a risk factor for brain atrophy and gl...
Abstract—Background: Postprandial plasma glucose (PPG) excursion is a significant determinant of ove...
International audienceBackground: Glucometabolic changes, such as high glycemic load (GL) diet and i...
Type 2 diabetes mellitus (T2DM) is becoming increasingly prevalent in the US, especially in older ad...
ObjectivesAbnormally high glucose levels (dysglycemia) increase with age. Epidemiological studies su...
Type 2 diabetes predicts accelerated cognitive decline and brain atrophy. We hypothesized that impai...
<p>At night, glycemic variability declined in type 2 DM in GVC<sub>2–4</sub> and in controls in GVC<...